Menu

Investing in AI: Benefits, Regulatory Challenges

> Listen on Spotify
> Listen on Amazon Music
> Listen on iHeart

No discussion regarding the future is complete unless AI is incorporated.

In this episode, Konstantina Katcheves of Teva Pharmaceuticals and Sanskriti Thakur of TOWER Capital Group provide their insights on the impact of not only the benefits of the technology but the regulatory challenges and uncertainty surrounding AI.

Host

⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Lori Ellis⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, Head of Insights, BioSpace

Guests

Konstantina Katcheves, Senior Vice President, Innovative Medicines Global Business Development and Acquisitions, Teva Pharmaceuticals

Sanskriti Thakur, Chairwoman, TOWER Capital

Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organization.

Related Posts

Back To Top
the Ivy

The Ivy is our flagship newsletter delivered 3x per week (Mon, Wed, Fri) with a focus on investments that can stand the test of time. Investors who seek undervalued companies, passive income, or top-rated ETFs will find The Ivy to be the definitive financial newsletter.

the Burst

If you trade the markets seeking to find the next growth stock, The Burst was created for you. In this newsletter (delivered Tue/Thu), we spotlight companies that are changing the world as well as cryptocurrencies and blockchain projects disrupting the status quo.

the Spotlight

In our weekly Spotlight newsletter, we shine a light on “stand-out” companies that have high potential. You will also find an assortment of “big picture” topics covered, from economic insights to stock market outlook.

the Daily

We aggregate some of the best up to date investing stories and news from around the web and deliver it to you each day in The Daily.

Enter your email to join the tens of thousands of traders and investors already taking advantage of the complimentary Summa Money newsletters


© Summa Money 2024
Powered by WordPress • Themify WordPress Themes